Medscint

Empowering medical physicists to implement cutting-edge radiation therapy techniques, we offer a revolutionary line of adaptable optical dosimetry solutions. Our patented HYPERSCINT real-time dose measurement detectors are renowned for their unmatched accuracy, particularly in challenging scenarios like small-field dosimetry, adaptive radiotherapy (ex. MR-Linac), and ultra-high dose-rate (ex. FLASH-RT). Across the United States, Canada, and Europe, professionals from the field have already embraced Medscint solutions to advance the frontiers of radiation therapy, and ultimately enhance cancer care outcomes

Dosimetry,medical physics,radiation therapy,dose measurements,scintillation dosimetry,scintillators,quality assurance,radiation oncology,plastic scintillator,dose detector,adaptive radiotherapy qa,small field dosimetry,flash radiotherapy,uhdr radiotherapy,image guided radiotherapy qa,targeted radiotherapy qa,and real-time dosimetry

Medscint operates in the Medical device industry.

Medscint's revenue is 11m - 100m

Medscint has 11 - 50 employees.